Floatz logo

m032

Anaplastic Astrocytoma or Gliosarcoma

University of Alabama at Birminghamgene_therapyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Anaplastic Astrocytoma or Gliosarcoma cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

m032 is also rated in:

glioblastomaDormant
CCC
Indicative ·
50 / 100
View asset →
anaplastic astrocytomaDormant
CC
Indicative ·
45 / 100
View asset →
gliosarcomaDormant
CC
Indicative ·
45 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →